Bausch Stock Today


USD 6.84  0.55  7.44%   

Market Performance
1 of 100
Odds Of Distress
Over 66
Bausch Health is trading at 6.84 as of the 7th of October 2022, a -7.44 percent decrease since the beginning of the trading day. The stock's open price was 7.39. Bausch Health has more than 66 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Bausch Health Companies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 11th of December 2021 and ending today, the 7th of October 2022. Click here to learn more.
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company has 359.33 M outstanding shares of which 16.33 M shares are currently shorted by investors with about 3.01 days to cover. More on Bausch Health Companies

Moving against Bausch Health

-0.63BLNKBlink Charging Normal TradingPairCorr
-0.56AXPAmerican Express Earnings Call  Next WeekPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Bausch Health Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bausch Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bausch Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Bausch Health has very high historical volatility over the last 90 days
Bausch Health has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 8.33 B. Reported Net Loss for the year was (407 M) with profit before taxes, overhead, and interest of 6.04 B.
About 73.0% of the company shares are held by institutions such as insurance companies
Latest headline from Bausch Health exotic insider transaction detected
ChairmanWilliam Humphries
Average Analyst Recommendation
Analysts covering Bausch Health report their recommendations after researching Bausch Health's financial statements, talking to executives and customers, or listening in on Bausch Health's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Bausch Health Companies. The Bausch consensus assessment is calculated by taking the average forecast from all of the analysts covering Bausch Health.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Bausch Health's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Bausch Health Companies (BHC) is traded on New York Stock Exchange in USA and employs 19,600 people. The company currently falls under 'Mid-Cap' category with total capitalization of 2.66 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bausch Health's market, we take the total number of its shares issued and multiply it by Bausch Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Bausch Health Companies runs under Healthcare sector within Drug Manufacturers—Specialty & Generic industry. The entity has 359.33 M outstanding shares of which 16.33 M shares are currently shorted by investors with about 3.01 days to cover. Bausch Health Companies has about 1.25 B in cash with 920 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.45.
Check Bausch Health Probability Of Bankruptcy
Bausch Health Companies retains a total of 359.33 Million outstanding shares. The majority of Bausch Health Companies outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bausch Health Companies to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bausch Health. Please pay attention to any change in the institutional holdings of Bausch Health Companies as this could imply that something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Bausch Ownership Details

Bausch Stock Price Odds Analysis

What are Bausch Health's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Bausch Health jumping above the current price in 90 days from now is about 52.33%. The Bausch Health Companies probability density function shows the probability of Bausch Health stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Bausch Health has a beta of 0.9157 suggesting Bausch Health Companies market returns are sensitive to returns on the market. As the market goes up or down, Bausch Health is expected to follow. Additionally, the company has an alpha of 0.1348, implying that it can generate a 0.13 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 6.84HorizonTargetOdds Above 6.84
47.57%90 days
Based on a normal probability distribution, the odds of Bausch Health to move above the current price in 90 days from now is about 52.33 (This Bausch Health Companies probability density function shows the probability of Bausch Stock to fall within a particular range of prices over 90 days) .

Bausch Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Bausch Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bausch Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bausch Health's value.
InstituionSecurity TypeTotal SharesValue
Icahn Carl CCommon Shares34.7 M290.3 M
Paulson Co IncCommon Shares26.4 M221 M
Mason Capital Management LlcCall Options3.2 M27.2 M
View Bausch Health Diagnostics

Bausch Health Companies Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bausch Health market risk premium is the additional return an investor will receive from holding Bausch Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bausch Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Bausch Health's alpha and beta are two of the key measurements used to evaluate Bausch Health's performance over the market, the standard measures of volatility play an important role as well.

Bausch Stock Against Markets

Picking the right benchmark for Bausch Health stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bausch Health stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bausch Health is critical whether you are bullish or bearish towards Bausch Health Companies at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bausch Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Optimizer Now


Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module

Bausch Health Corporate Directors

Bausch Health corporate directors refer to members of a Bausch Health board of directors. The board of directors generally takes responsibility for the Bausch Health's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bausch Health's board members must vote for the resolution. The Bausch Health board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Sarah Kavanagh - Independent DirectorProfile
Richard DeSchutter - Independent DirectorProfile
Robert Hale - Independent DirectorProfile
Richard Schutter - Independent DirectorProfile

Invested in Bausch Health Companies?

The danger of trading Bausch Health Companies is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bausch Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bausch Health. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bausch Health Companies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Bausch Health Companies information on this page should be used as a complementary analysis to other Bausch Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Bausch Stock analysis

When running Bausch Health Companies price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
CEO Directory
Screen CEOs from public companies around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Is Bausch Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bausch Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.